Although SHM16 was established by the immunization of A375 melanoma cells into mice and developed as an agonistic mAb against EphA2 [22], SHM16 is not available to Western blot with the denatured form of EphA2, possibly due to its recognition of a structural epitope (Supplementary Fig. 1). The gene discussed is EPHA2; the disease is melanoma.